Instead, Schlesinger argues that as San Antonio and the world emerge from the COVID-19 pandemic, its citizens can become more aware of the need ...
News
- Texas Biomed CEO Dr. Larry Schlesinger
- Seattle Genetics: 1Q Earnings Snapshot
The biotechnology company posted revenue of $234.5 million in the period, also surpassing Street forecasts. Seven analysts surveyed by Zacks ...
- Nerium Biotechnology Provides Update on Status of its Annual Filings - Announces Reliance on ...
SAN ANTONIO , April 30, 2020 /CNW/ - Nerium Biotechnology, Inc. (the "Company") is providing an update on the status of its annual consolidated ...
- Texas still won't say which nursing homes have COVID-19 cases, families demanding answers
... University's Center for Health Law Policy, Biotechnology and Bioethics. ... San Antonio, the state's second-largest city, tried to be proactive before ...
- Report finds two major metros are the biggest sources of new Houstonians
Chicago (3.3 percent), New York (3.4 percent), and San Antonio (22.8 ... early next month and is sponsored by Genentech, a biotechnology company.